Lumira Capital invests in $43 mln financing of Cardiac Dimensions
Cardiac Dimensions Inc has added US$15.2 million to a previously announced round of financing, bringing the deal’s total to US$43 million. The latest tranche was provided by European venture capital firm Life Sciences Partners and U.S. firm Aperture Venture Partners. They join existing investors, which include Canadian venture capital firm Lumira Capital. Cardiac, a U.S. developer of minimally invasive treatments for heart failure and related cardiovascular conditions, said the funds will be used to support clinical trials, the expansion of research activity and commercial operations.
11 March 2015•4 mins read
